On behalf of the SRT’s board of directors, we would like to invite you to represent your company as an esteemed member of the Society for RNA Therapeutics’ Industry Advisory Council (IAC). Membership in the inaugural class of the SRT IAC is reserved for scientists from organizations who are deeply committed to advancing the field of RNA Therapeutics.
The charge of the SRT’s Industry Advisory Council is to advise the SRT board of directors on issues of importance, and so we place a high value on your involvement. The IAC will lead in the development of programs and services to increase the value and influence of the Society to industry partners, academics, lawmakers, and thought leaders who engage with SRT.
The IAC is best suited for companies who have an interest in both strategic and financial contribution to help advance the field of RNA Therapeutics globally.
The primary functions of the IAC are to:
If you would like to be part of this remarkable opportunity to transform treatment options for countless people, please complete this short form and Tracy Schorle, Managing Director, SRT, will get in touch with you.